Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

被引：0
|
作者：
Fujita, K. [1 ]
机构：
[1] Natl Hosp Org Kyoto Med Ctr, Resp Med, Kyoto, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3918
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Hashimoto, Masayuki
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [2] Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors
    Im, Yunjoo
    Lee, Jeeyun
    Kim, Seok Jin
    Koh, Won-Jung
    Jhun, Byung Woo
    Lee, Se-Hoon
    RESPIRATORY MEDICINE, 2020, 161
  • [3] INCIDENCE AND PREDICTORS OF CARDIAC TOXICITY IN CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Hu, Jian
    Pappan, Nikos
    Shnoda, Mina
    Doyle, Mark
    Kyvernitakis, Andreas
    Poornima, Indu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3327 - 3327
  • [4] Incidence of Pneumonitis in Metastatic Lung Cancer Patients Receiving Immune Checkpoint Inhibitors With or Without Thoracic Radiation Therapy
    Hwang, W.
    Niemierko, A.
    Willers, H.
    Gainor, J.
    Keane, F. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S150 - S150
  • [5] The impact of cancer pain on survival of lung cancer patients receiving immune checkpoint inhibitors
    Wang, S.
    Ye, Z-H.
    Zhang, J.
    Lee, T. T. L.
    Wai, A. K. C.
    Kong, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S890 - S890
  • [6] Should immune checkpoint inhibitors be contraindicated in lung cancer patients with latent tuberculosis?
    Haddad, Fady G. H.
    Kattan, Clarisse
    Kattan, Joseph
    IMMUNOTHERAPY, 2020, 12 (11) : 759 - 762
  • [7] Incidence and economic burden of infections in cancer patients receiving immune checkpoint inhibitors.
    Nalluru, Swarna Sri
    Piranavan, Paramarajan
    Narimiti, Anvesh
    Shah, Shanil
    Siddiqui, Ahmad Daniyal
    Abraham, George
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Hyperprogression in Patients With Cancer Receiving Immune Checkpoint Inhibitors
    Sehgal, Kartik
    JAMA NETWORK OPEN, 2021, 4 (03)
  • [9] CARDIAC IMMUNE-RELATED ADVERSE EVENTS IN LUNG CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Kumar, Sany
    Fowler, Cosmo
    Thota, Ajit K.
    Pastores, Stephen M.
    CHEST, 2023, 164 (04) : 363A - 363A
  • [10] Prevalence of Latent Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A South-East London Cohort Study
    Paine, Gabriel Wisenfeld
    Cox, Rosie
    Evans, Rosa
    Hudson, Jake
    Baker, Lucy
    Simpson, Thomas
    LUNG CANCER, 2025, 200
12345